| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |